Indian firms commit $20.5 billion in US investments
Indian firms announced $20.5 billion in investments across the US, focusing on pharmaceuticals, technology, and engineering. Sun Pharmaceutical's planned $11.75 billion acquisition of Organon & Co. highlights the significant commitment to job creation and supply chain enhancement.
pre-market1 source ↓written by the desknot a recommendation
- in investments
- $20.5 billion
- allocated to pharma
- $19.1 billion
- acquisition of Organon
- $11.75 billion
Indian industry leaders pledged $20.5 billion in investments across the U.S. at the SelectUSA Investment Summit 2026. Key sectors include pharmaceuticals, technology, and engineering, with $19.1 billion allocated to pharma alone. Notably, Sun Pharmaceutical plans an $11.75 billion acquisition of Organon & Co. This move is expected to create thousands of jobs and enhance supply chains.
Not investment advice. For informational purposes only.